Associate professor
Otolaryngology (ENT)
Dr. Miriam Lango, MD
|
|
Give Review
Miriam Lango is an expert in the field of Otolaryngology (ENT). He attended NYU School of Medicine. He received awards:"Top Doc", "Philadelphia Magazine", "CMS Meaningful Use Stage 1 Certification", "Institutional grant award", "Resident research award", "Member" and "Fellow (FACS)". Miriam Lango has written publications. He has 38 publications published with PubMed. The lastest publication is: 'Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma.' Miriam Lango accepts all Medicare patients.
Publications
- p16 status, pathologic and clinical characteristics, biomolecular signature, and long-term outcomes in Head and neck squamous cell carcinomas of unknown primary.
- Baseline health perceptions, Dysphagia, and survival in patients with head and neck cancer.
- Biodistribution and Radiation Dosimetry of 18F-CP-18, a Potential Apoptosis Imaging Agent, as Determined from PET/CT Scans in Healthy Volunteers.
- Quantification of excision repair cross complementing group 1 (ERCC1) and survival in p16-negative squamous cell head and neck Cancers.
- Dysplasia at the margin? Investigating the case for subsequent therapy in 'Low-Risk' squamous Cell carcinoma of the oral tongue.
- Malignant transformation of respiratory papillomatosis in a solid-organ transplant patient: case report and literature review.
- A pilot study of psychosocial functioning and vascular endothelial growth factor in head and neck Cancer patients.
- Extranodal extension of Metastatic Papillary Thyroid Carcinoma: Correlation with biochemical endpoints, nodal persistence and systemic Disease progression.
- Informational Needs of Head and Neck Cancer Patients.
- Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of Head-a...
- Increased recurrences using intensity-modulated radiation therapy in the postoperative setting.
- Surgery in the multimodality treatment of sinonasal malignancies.
- Impact of neck dissection on long-term feeding tube dependence in patients with head and neck Cancer treated with primary radiation or chemoradiation.
- Postradiotherapy neck dissection for Head and neck squamous cell carcinoma: pattern of pathologic residual carcinoma and prognosis.
- Multimodal treatment for head and neck Cancer.
- Controversies in surgical management of the node-positive Neck after chemoradiation.
- Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck Cancer growth and resistance to EGFR targeting.
- Gastrin-releasing peptide receptor-mediated autocrine growth in squamous cell carcinoma of the Head and neck.
- Head and neck sarcomas: a comprehensive Cancer center experience.
- Metastatic cervical Carcinoma from an unknown primary: Literature review.
- The role of Neck dissection in the combined modality therapy setting.
- Intensity-modulated radiotherapy for early larynx Cancer: is there a role?
- Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal Cancer: the Fox Chase Cancer Center experience.
- Initial results of a Phase I dose-escalation trial of concurrent and maintenance erlotinib and reirradiation for recurrent and new primary head-and-neck Cancer.
- Responsiveness to the retinoic acid receptor-selective retinoid LGD1550 correlates with abrogation of transforming growth factor alpha/epidermal growth factor receptor...
- TGF-alpha antisense gene therapy inhibits Head and neck squamous cell carcinoma growth in vivo.
- Targeting growth factor receptors: integration of novel therapeutics in the management of head and neck Cancer.
- Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in Head and neck ...
- Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy.
- Discordant, organ-specific regulation of insulin-like growth factor-I messenger ribonucleic acid in insulin-deficient diabetes in rats.
- An allelotype of papillary thyroid Cancer.
- Antihypertensive agents that limit ventricular hypertrophy inhibit cardiac expression of insulin-like growth factor-I.
- Impact of chromosome 14q loss on survival in primary Head and neck squamous cell carcinoma.
- Head and neck Cancer in nonsmokers: a distinct clinical and molecular entity.
- Two distinct regions of loss on chromosome arm 4q in primary Head and neck squamous cell carcinoma.
- Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder Cancer patients.
- Idiopathic hypereosinophilic syndrome with Skull base involvement.
Schools
New York University School Of Medicine
University Health Center Of Pittsburgh
Procedures Preformed
- Antrostomy and Antrotomy (Sinus Surgery)
- Dacryocystorhinostomy
- Diagnostic Nasal and-or Sinus Endoscopy
- Ethmoidectomy (Sinus Surgery)
- View All
Conditions Treated
- Acute Laryngitis
- Allergic Rhinitis
- Bell's Palsy
- Chronic Sinusitis
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Personal Choice PPO
- Regional Pref Network EPO
- Regional Pref Network HMO
- Regional Pref Network HMO+
- Regional Pref Network POS+
- Regional Pref Network PPO
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Gateway Health Plan
- Geisinger Health Plan
- Community Blue PPO
- Direct Access
- Horizon Blue Cross Blue Shield HMO
- Horizon Blue Cross Blue Shield POS
- Horizon Blue Cross Blue Shield PPO
- Choice Care PPO
- Keystone Health Plan East HMO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- QualCare HMO
- QualCare PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Top Doc
- Philadelphia Magazine
- CMS Meaningful Use Stage 1 Certification
- Institutional grant award
- Resident research award
- Member
- Fellow (FACS)
Education
-
University of Pittsburgh Medical Center -
NYU School of Medicine
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Drug Facts
| NPI NUMBER | 1457372153 | |
| NPPES Provider LastName | LANGO | |
| NPPES Provider FirstName | MIRIAM | |
| NPPES Provider ZIPCode | 191112434 | |
| NPPES Provider State | PA | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 90.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 13.33 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457372153 |
| Last Name Of The Provider | LANGO |
| First Name Of The Provider | MIRIAM |
| View All |
Similar Doctors
|
|
Dr. Shaun S. Baker, DO |
|
|
Dr. Gary Linkov, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lindsay A. Goodstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Sciarrino, MD |
|
|
Dr. Akshay Sanan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason L. Yu, MD |
|
|
Dr. Andres M. Bur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander A. Farag, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elina M. Toskala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan C. Borek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward B. Gaynor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence Tom, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lisa M. Elden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad Millman, MD
This Doctor is OpenDoctor Recommended.
|